Risk factors for Creutzfeldt-Jakob disease: A reanalysis of case-control studies

Neurology

Volumn 46, Issue 5, 1996, Pages 1287-1291

  Wientjens, D P W M ^a   Davanipour, Z ^b   Hofman, A ^a   Kondo, K ^c   Matthews, W B ^d   Will, R G ^e   Van Duijn, C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HOKKAIDO UNIVERSITY   (Japan)

^d RADCLIFFE INFIRMARY   (United Kingdom)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; COW; CREUTZFELDT JAKOB DISEASE; DEMENTIA; ENVIRONMENTAL EXPOSURE; FAMILY HISTORY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; POLIOMYELITIS; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SHEEP; UNITED KINGDOM; UNITED STATES;

EID: 0029904189     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.46.5.1287     Document Type: Article

References (26)

1. Prusiner SB, Hsiao KH. Human prion diseases. Ann Neurol 1994;35:385-395.
2. Brown P, Cathala F, Raubertas RF, et al. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987;37:895-904.
3. Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy Creutzfeldt-Jakob disease: the nature and progression of spongiform change. Brain 1978;101:333-344.
4. Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982;45:235-238.
5. Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 1988;69:766-769.
6. Bernouilli C, Siegfried J, Baumgartner G, et al. Danger of accidental person to person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977;1:478-479.
7. Duffy P, Wolf J, Collins G, et al. Possible person to person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-693.
8. Powell-Jackson J, Weller RO, Kennedy P, et al. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 1985;2:244-246.
9. Gibbs CJ, Joy A, Heffner R, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 1985;313:734-739.
10. Brown P, Gajdusek DC, Gibbs CJ, et al. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985;313:728-731.
11. Cochius JI, Mack K, Burns RJ, et al. Creutzfeldt-Jakob disease in a recipient of human pituitary gonadotrophin. Aust NZ J Med 1990;20:592-593.
12. Bobowick AR, Brody JA, Matthews MR, et al. Creutzfeldt-Jakob disease: a case-control study. Am J Epidemiol 1973;98: 381-394.
13. Kondo K, Kuroiwa Y. A case-control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982;11:377-381.
14. Davanipour Z, Alter M, Sobel E, et al, Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985;35:1483-1486.
15. Davanipour Z, Alter M, Sobel E, et al. A case-control study of Creutzfeldt-Jakob disease: dietary risk factors. Am J Epidemiol 1985;122:443-451.
16. Davanipour Z, Alter M, Sobel E, et al. Transmissible virus dementia: evaluation of a zoonotic hypothesis. Neuroepidemiology 1986;5:194-206.
17. Harries-Jones R, Knight R, Will RG, et al. Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988;51:1113-1119.
18. Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-188.
19. Schlesselman JL. Case-control studies. New York: Oxford University Press, 1982.
20. Collinge J, Brown J, Hardy J, et al. Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 1992;115:687-710.
21. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991;337:1441-1442.
22. Palmer MS, Dryden AJ, Hughes JT, et al. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991;352:340-341.
23. Collinge J, Owen F, Poulter H, et al. Prion dementia without characteristic pathology. Lancet 1990;336:7-9.
24. Amouyel P, Vidal O, Launay JM, et al. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 1994;344:1315-1318.
25. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
26. Alperovitch A, Brown P, Weber T, et al. Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet 1994; 343:918.